October 22, 2014
Mohenjo
Medical
Abbott, Abbott FreeStyle Libre, amazon, blood glucose readings, business, Business News, cellphone-sized device, daily insulin injections, diabetes care, display blood glucose, doctors and patients can’t wait, Europe, FreeStyle Libre system, gathered by a sensor on the arm, Gopalakrishnan, Hotels, human-rights, insulin injections, medical company Abbott, medicine, mental-health, Prabahar Gopalakrishnan, research, revolution in diabetes care, Science, Science News, Sugar, technology, Technology News, Testing your sugar without needles, Tha globe and mail, travel, type 1 diabetic, vacation, without blood droplets
Click link below picture
.
Now that is cool: Testing your sugar without needles and without blood droplets.
In Europe, the medical company Abbott has just released its FreeStyle Libre system, which may usher in a revolution in diabetes care. And both doctors and patients can’t wait.
Prabahar Gopalakrishnan, 26, is a type 1 diabetic who has taken daily insulin injections since the age of seven. “I’ve probably pricked my fingers almost 15,000 times so far,” he tells me.
.
The Abbott FreeStyle Libre uses a cellphone-sized device, left, to display blood glucose readings gathered by a sensor placed on the arm, right..
.
Click link below for article:
.
__________________________________________
October 16, 2014
Mohenjo
Medical
400000 people in Britain, amazon, breakthrough, business, Business News, cure for diabetes, diabetes, Harvard University, Hotels, huge quantities of insulin-producing cells, human-rights, insulin injections, insulin-producing cells, Jen Grieves, journal Cell, medicine, mental-health, millions of beta cells, quantities, research, Science, Science News, technology, Technology News, the telegraph, travel, type 1 diabetes, vacation
Click link below picture
.
Harvard University has produced the vast quantities of insulin-producing cells needed for transplants
A cure for diabetes could be imminent after scientists discovered how to make huge quantities of insulin-producing cells, in a breakthrough hailed as significant as antibiotics.
Harvard University has, for the first time, managed to manufacture the millions of beta cells required for transplantation.
It could mean the end of daily insulin injections for the 400,000 people in Britain living with Type 1 diabetes.
.
Jen Grieves.
.
Click link below for article and videos:
.
__________________________________________
James' World 2 